tirzepatide off shortage Update: On December 19th the FDA ruled the tirzepatide was resolved, however is giving a grace period for compounding pharmacies to continuing manufacturing. This grace period is 60 days. On Drugmakers battle pharmacies over compounded

Depressive-like behavior - In male rats, supplementation with N-3 PUFAs (postnatal day (P)41-61) [41] or sodium butyrate (P60-67) [42] mitigated the postnatal stress (POS)-induced depressive-like behavior in the forced swim test (FST) at two months of age [41] and at P67 [42]

In SUSTAIN 6 the preapproval CVOT for subcutaneous semaglutide the rate of CV death, nonfatal myocardial infarction, or nonfatal stroke was significantly lower among patients receiving semaglutide (6.6% [108/1,648]) than among those receiving placebo (8.9% [146/1,649]

Its possible that the study wasnt long enough to show all the beneficial effects over time, Chen says

More than 20 million Americans go on a fad diet every year